ELKS Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP9050c
Background:
ELKS is a protein that was regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport.
Other Names:
ELKS/Rab6-interacting/CAST family member 1, ERC-1, Rab6-interacting protein 2, ERC1, ELKS, KIAA1081, RAB6IP2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9050c was selected from the Center region of human ELKS. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ERC1
Gene ID: 23085
Primary Accession: Q8IUD2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
ELKS is a protein that was regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport.
Other Names:
ELKS/Rab6-interacting/CAST family member 1, ERC-1, Rab6-interacting protein 2, ERC1, ELKS, KIAA1081, RAB6IP2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9050c was selected from the Center region of human ELKS. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ERC1
Gene ID: 23085
Primary Accession: Q8IUD2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review